Uncategorized related Press Releases
Marina Biotech Announces Closure of Cambridge Site and Consolidation of R&D Operations in Bothell, WA
Marina Biotech Announces Closure of Cambridge Site and Consolidation of R&D Operations in Bothell, WACompany Initiates Dosing in the First Patient in Cohort 2 of the START-FAP Clinical Trial Read more...
Actelion announces Full Year 2011 financial results
Actelion announces Full Year 2011 financial results Product sales of CHF 1,713.0 million, up 7% in local currencies - Non-GAAP EBIT of CHF 520.6 million, up 8% in local currencies - 2011 Non-GAAP Read more...
InnaVirVax lands $4.9 Million in Series B funding Round
InnaVirVax lands $4.9 Million in Series B funding RoundThis second round of funding was lead by the Pradeyrol Développement family office along with the private equity fund Fa Dièse, Read more...
KARO BIO TERMINATES THE EPROTIROME PROGRAM
STOCKHOLM, February 14, 2012 - Karo Bio AB (publ) has decided to discontinue the development program for eprotirome after an animal study has demonstrated unwanted effects following long-term Read more...
FDA Approves ZIOPTANTM (tafluprost ophthalmic solution), Merck's Once-Daily, Preservative-Free Ophthalmic Medication
FDA Approves ZIOPTANTM (tafluprost ophthalmic solution), Merck's Once-Daily, Preservative-Free Ophthalmic Medication ZIOPTAN is a New and Effective Prostaglandin Analog Option for Lowering Elevated Read more...
Foundation Medicine and Dana-Farber Cancer Institute Identify Novel Genomic Alterations in Lung and Colorectal Cancer
CAMBRIDGE, Mass., Feb 13, 2012 (BUSINESS WIRE) -- Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer gene analysis to routine clinical care, and Dana-Farber Read more...
BioClinica Reports Record Service Revenue for the Fourth Quarter and Year End 2011
NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced its financial results for the fourth quarter and year Read more...
New virtual tool may provide more accurate diagnosis of genetic mutations
New virtual tool may provide more accurate diagnosis of genetic mutationsNew technology described in the Journal of Molecular Diagnostics Philadelphia, PA, February 6, 2012 - DNA sequencing to detect Read more...
Ocimum Biosolutions Is Winner of Bioexcellence Award ( Bioinformatics and Systems Biology) at Bio India 2012
Ocimum Biosolutions Is Winner of Bioexcellence Award ( Bioinformatics and Systems Biology) at Bio India 2012 Press release from: Ocimum Biosolutions (openPR) - Hyderabad, Andhra Pradesh, India, Read more...
Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug
Mobius TherapeuticsTM Receives Final FDA Approval for New Glaucoma DrugFDA Approves Mitosol® for Immediate Production and Use in Glaucoma Surgery By Mobius Therapeutics, LLCPublished: Thursday, Read more...
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
